Immune reconstitution inflammatory syndrome associated with disseminated Mycobacterium sherrisii infection

International Journal of STD and AIDS

Volumn 23, Issue 5, 2012, Pages 369-370

  Ho, J ^a   Balm, M ^a   Huggan, P ^a   Venkatachalam, I ^a   Archuleta, S ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Disseminated; Granulomatous hepatitis; Immune reconstitution inflammatory syndrome; Mycobacterium sherrisii; Mycobacterium simiae; Non tuberculous mycobacterium

Indexed keywords

ALKALINE PHOSPHATASE; CLARITHROMYCIN; CORTICOSTEROID; EFAVIRENZ; ETHAMBUTOL; GAMMA GLUTAMYLTRANSFERASE; ISONIAZID; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; PYRAZINAMIDE; RIFAMPICIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISSEMINATED MYCOBACTERIUM SHERRISII INFECTION; FEMALE; FEVER; HEPATITIS; HEPATOSPLENOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIVER BIOPSY; LYMPHADENOPATHY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM SHERRISII; NAUSEA; PERICARDIAL EFFUSION; PRIORITY JOURNAL; VOMITING;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

EID: 84861779402     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.011311     Document Type: Article

References (10)

1. Selvarangan R, Wu WK, Nguyen TT, et al. Characterisation of a novel group of Mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol 2004;42:52-9
2. van Ingen J, Tortoli E, Selvarangan R, et al. Mycobacterium sherrisii sp. nov: a slow growing nonchromogenic species. Int J Syst Evol 2011;61:1293-8
3. Tortoli E, Galli L, Andebirhan SB, Chiappini E, de Martino M, Brown-Elliott BA. The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS. AIDS 2007;21:1496-8
4. Loulergue P, Lamontagne F, Vincent V, Rossier A, Pialoux G. Mycobacterium sherrisii: a new opportunistic agent in HIV infection? AIDS 2007;21:893-4
5. Gamperli A, Bosshard PP, Sigrist T, et al. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 2005;43:4283-5
6. Crump JA, van Ingen J, Morrissey AB, et al. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Inf Dis 2009;15:53-5
7. Ngan GJY, Ng LM, Jureen R, Lin RTP, Teo JWP. Development of multiplex PCR assays based on the 16S-23S rRNA internal transcribed spacer for the detection of clinically relevant nontuberculous mycobacteria. Lett Appl Microbiol 2011;52:546-54
8. Ballard J, Turenne CY, Wolfe JN, Reller LB, Kabani A. Molceular characterisation of nontuberculous mycobacteria isolated from human cases of disseminated disease in the USA, Thailand, Malawi and Tanzania. J Gen Appl Microbiol 2007;53:153-7
9. Tortoli E, Mariottini A, Mazzarelli G. Mycobacterium sherrisii isolation from a patient with pulmonary disease. Diag Microbiol Inf Dis 2007;57:221-3
10. Sison JP, Yao Y, Kemper CA, et al. Treatment of Mycobcaterium avuim complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J Inf Dis 1996;173:677-83